An Open-Label, Single-center, Parallel, Phase 1 Study to Determine the Pharmacokinetics of Single- and Multiple- Oral Doses of TAK-438 10 mg and 20 mg in Healthy Adult Chinese Subjects
Phase of Trial: Phase I
Latest Information Update: 05 Feb 2019
At a glance
- Drugs Vonoprazan (Primary)
- Indications Duodenal ulcer; Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Reflux oesophagitis
- Focus Pharmacokinetics
- Sponsors Takeda
- 18 Sep 2017 Status changed from recruiting to completed.
- 07 Jul 2017 Planned End Date changed from 20 Jul 2017 to 18 Aug 2017.
- 07 Jul 2017 Planned primary completion date changed from 20 Jul 2017 to 18 Aug 2017.